07 Jan 2001

Delmuno® 2,5 (Delmuno® 2,5/2,5 mg/-5/5 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Delmuno® 2,5 | 2,5 mg | -5 | 5 mg

Behandl. der essentiellen Hypertonie bei Pat. deren Blutdruck mit den Einzelsubstanzen in gleichen Dosen entspr. der angestrebten fixen Komb. eingestellt ist.

Delmuno® 2,5 Description, Presentation and Dosage

Delmuno® 2,5 Description

Delmuno® 2,5 Drug Class Description

Andere Kombinationen mit ACE-Hemmern

Delmuno® 2,5 Drug Description

1 Filmtbl. enth.: Felodipin 2,5 mg/5 mg, Ramipril 2,5 mg/5 mg.

Delmuno® 2,5 Generic Name

Delmuno® 2,5/2,5 mg/-5/5 mg Filmtabletten

Delmuno® 2,5 Presentation

Delmuno® 2,5 Presentation

Delmuno® 2,5/2,5 mg/-5/5 mg

Delmuno® 2,5 Manufacturer

Aventis Pharma

Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Delmuno® 2,5 Dosage

Delmuno® 2,5 Adult Dosage

Lactose, Hydroxypropylcellulose, Poly(O-2-hydroxypropyl,O-methyl)cellulose, Maisstärke, mikrokristalline Cellulose, Macrogol 6000, Macrogolglycerolhydroxystearat, Propylgallat, Aluminium-Natrium-silicat-Komplex, Octadecylhydrogenfumarat, Natriumsalz, Eisenoxidhydrat und Eisen(III)-oxid (E 172), Titandioxid (E 171), Paraffin.

Delmuno® 2,5 Precautions, Reactions and Contraindications

Delmuno® 2,5 Special Precautions

Delmuno® 2,5 Special Precautions

A 95 a-d, g-j, C 3 a, c. Schlaganfall (6 Mon.), Orthostase, instabile Angina pectoris, akuter Myokardinfarkt (8 Wo.), bei Herzinsuffizienz nach Myokardinfarkt zusätzl. anhaltende Hypotension, atrioventrikuläre Überleitungsstörungen 2. u. 3. Grades, lebensbedrohliche ventrikuläre Arrhythmien, Cor pulmonale, Dialyse, schwere Niereninsuffizienz (GFR

Related Drugs - Cardiology

Back to top